In 2023, the share of China's scientific publications in biomedical engineering among the world’s top 10% cited works was significant. The forecast data from 2024 to 2028 shows a steady increase from 15.35% to 17.78%, indicating a positive trend in the global impact of Chinese publications. Year-on-year percentage variations include consistent growth of around 2-4% annually, suggesting a strengthening influence in this field. The Compound Annual Growth Rate (CAGR) over this period underscores a solid upward trajectory.

Future trends to watch for include:

Increased collaboration between Chinese institutions and leading global research entities.
Enhanced funding and policy support from the Chinese government for innovation in biomedical engineering.
Potential disruptions or accelerations in scientific output by advancements in adjacent technologies such as AI and biotechnology.